RELEASE: Gottheimer Visits BD Thanks Workers, Discusses COVID19 Diagnostic Development, Injection Devices, and Vaccinations

Jun 16, 2020

Above: Gottheimer with CEO and President Tom Polen.

FRANKLIN LAKES, NJ – On June 16, 2020, U.S. Congressman Josh Gottheimer (NJ-5) visited Becton, Dickinson and Company, commonly known as BD, to thank workers, discuss the development of COVID19 assays, view injection and testing devices, and talk about supply chain disruptions. 

“I want to thank everyone at BD for having me here today and commend them on the critical role they play during this pandemic by providing vital resources to our hospitals, laboratories, and health departments,” said Congressman Josh Gottheimer (NJ-5). “It’s no question that our supply chains have been severely impacted by this pandemic and it’s companies like BD that will help us beat the virus by providing these important supplies to our communities.” 

“As one of the world’s leading medical technology companies, BD has been working with urgency to deploy our capabilities, expertise, and scale to equip healthcare providers and governments with solutions that are essential to addressing the COVID-19 crisis, from supporting research to developing rapid diagnostic tests that can help determine who has—and who had—the virus,” said CEO and President Tom Polen. “We have ramped up production of critical-to-COVID products that touch virtually every patient in a critical care setting, and BD stands ready to support a future global vaccination campaign by ensuring a supply of high quality injection devices. We are thankful for Congressman Gottheimer’s ongoing support and partnership as our associates work to help solve the most significant healthcare challenge in generations, making a positive impact on millions of lives around the world.”

Recently, Gottheimer led a bipartisan letter signed by 25 Members of Congress to House Leadership to address the shortage of needles and syringes needed to deploy a COVID-19 vaccine nationwide. To produce a single dose of a vaccine for every person in the U.S., more than 300 million syringes and needles are needed. If a vaccine requires more than one dose for deployment, our country could require much more. 

Last week, BD took part in a “Day of Thanks” to thank their associates for the work they have been doing during the pandemic and pledge their continued support to employees. 

Below: Gottheimer viewing BD Swabs

Below: Gottheimer viewing BD medical device

Below: Gottheimer viewing BD needles

Recent Posts

Apr 20, 2024

RELEASE: Problem Solver Gottheimer Helps Pass Critical Bipartisan Security and Humanitarian Aid Package for U.S. Allies — Ukraine, Israel, and Taiwan

WASHINGTON, DC — Today, Saturday, April 20, 2024, U.S. Congressman Josh Gottheimer (NJ-5) and Problem Solvers Caucus Co-Chair helped pass a $95 billion security aid package to provide critical security and humanitarian aid for America’s key democratic allies, Ukraine, Israel, and Taiwan. The package, which includes eight Gottheimer-led bills, all passed with bipartisan support. “After working […]

Apr 18, 2024

RELEASE: Gottheimer Remembers Jersey Firefighter and Labor Leader Bobby Allen on House Floor

WASHINGTON, DC — Today, April 18, 2024, U.S. Congressman Josh Gottheimer (NJ-5) honored and memorialized the life of Robert “Bobby” Allen, a Paterson firefighter and New Jersey labor leader, in a floor speech.  Video of Congressman Gottheimer’s floor speech can be found here. Bobby began his career with the Paterson Fire Department in 1992, serving as a […]

Apr 16, 2024

RELEASE: House Passes Gottheimer-led Bipartisan Resolution Condemning Antisemitic “From the River to the Sea” Chants

WASHINGTON, DC — Today, Tuesday, April 16, 2024, U.S. Congressman Josh Gottheimer (NJ-5), Congressman Anthony D’Esposito (NY-4), and Congressman Jared Moskowitz (FL-23) led a bipartisan resolution that successfully passed the House. The resolution, H.R. 883, condemns the chant “From the River to the Sea, Palestine Will be Free” as antisemitic. The resolution passed the House by a […]